These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. 8-Methylureido-10-amino-10-methyl-imidazo[1,2-a]indeno[1,2-e] pyrazine-4-ones: highly in vivo potent and selective AMPA receptor antagonists. Jimonet P; Chevé M; Bohme GA; Boireau A; Damour D; Debono MW; Genevois-Borella A; Imperato A; Pratt J; Randle JC; Ribeill Y; Stutzmann JM; Vuilhorgne M; Mignani S Bioorg Med Chem; 2000 Aug; 8(8):2211-7. PubMed ID: 11003165 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and structure-activity relationships of 4,10-dihydro-4-oxo-4H-imidazo[1,2-a]indeno[1,2-e]pyrazine derivatives: highly potent and selective AMPA receptor antagonists with in vivo activity. Stutzmann JM; Vuilhorgne M; Mignani S Mini Rev Med Chem; 2004 Feb; 4(2):123-40. PubMed ID: 14965286 [TBL] [Abstract][Full Text] [Related]
8. 8-Methylureido-4,5-dihydro-4-oxo-10H-imidazo[1,2-a]indeno[1,2-e]pyrazines: highly potent in vivo AMPA antagonists. Mignani S; Bohme GA; Boireau A; Cheve M; Damour D; Debono MW; Genevois-Borella A; Imperato A; Jimonet P; Pratt J; Randle JC; Ribeill Y; Vuilhorgne M; Stutzmann JM Bioorg Med Chem Lett; 2000 Mar; 10(6):591-6. PubMed ID: 10741560 [TBL] [Abstract][Full Text] [Related]
9. RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis. Canton T; Böhme GA; Boireau A; Bordier F; Mignani S; Jimonet P; Jahn G; Alavijeh M; Stygall J; Roberts S; Brealey C; Vuilhorgne M; Debono MW; Le Guern S; Laville M; Briet D; Roux M; Stutzmann JM; Pratt J J Pharmacol Exp Ther; 2001 Oct; 299(1):314-22. PubMed ID: 11561094 [TBL] [Abstract][Full Text] [Related]
10. LU 73068, a new non-NMDA and glycine/NMDA receptor antagonist: pharmacological characterization and comparison with NBQX and L-701,324 in the kindling model of epilepsy. Potschka H; Löscher W; Wlaź P; Behl B; Hofmann HP; Treiber HJ; Szabo L Br J Pharmacol; 1998 Nov; 125(6):1258-66. PubMed ID: 9863655 [TBL] [Abstract][Full Text] [Related]
11. 3,5-Dihydro-4H-2,3-benzodiazepine-4-thiones: a new class of AMPA receptor antagonists. Chimirri A; De Sarro G; De Sarro A; Gitto R; Quartarone S; Zappalà M; Constanti A; Libri V J Med Chem; 1998 Aug; 41(18):3409-16. PubMed ID: 9719593 [TBL] [Abstract][Full Text] [Related]
12. Synthesis of 1,4,7,8,9,10-hexahydro-9-methyl-6-nitropyrido[3,4-f]- quinoxaline-2,3-dione and related quinoxalinediones: characterization of alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (and N-methyl-D-aspartate) receptor and anticonvulsant activity. Bigge CF; Malone TC; Boxer PA; Nelson CB; Ortwine DF; Schelkun RM; Retz DM; Lescosky LJ; Borosky SA; Vartanian MG J Med Chem; 1995 Sep; 38(19):3720-40. PubMed ID: 7562904 [TBL] [Abstract][Full Text] [Related]
13. Neuroprotective and anticonvulsant effects of EGIS-8332, a non-competitive AMPA receptor antagonist, in a range of animal models. Gigler G; Móricz K; Agoston M; Simó A; Albert M; Benedek A; Kapus G; Kertész S; Vegh M; Barkóczy J; Markó B; Szabó G; Matucz E; Gacsályi I; Lévay G; Hársing LG; Szénási G Br J Pharmacol; 2007 Sep; 152(1):151-60. PubMed ID: 17603549 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and anticonvulsant activity of novel and potent 6,7-methylenedioxyphthalazin-1(2H)-ones. Grasso S; De Sarro G; De Sarro A; Micale N; Zappalà M; Puja G; Baraldi M; De Micheli C J Med Chem; 2000 Jul; 43(15):2851-9. PubMed ID: 10956193 [TBL] [Abstract][Full Text] [Related]
15. 7,8-Methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists. De Sarro A; De Sarro G; Gitto R; Grasso S; Micale N; Quartarone S; Zappalà M Bioorg Med Chem Lett; 1998 Apr; 8(8):971-6. PubMed ID: 9871522 [TBL] [Abstract][Full Text] [Related]
17. 1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists. Chimirri A; De Sarro G; De Sarro A; Gitto R; Grasso S; Quartarone S; Zappalà M; Giusti P; Libri V; Constanti A; Chapman AG J Med Chem; 1997 Apr; 40(8):1258-69. PubMed ID: 9111300 [TBL] [Abstract][Full Text] [Related]
18. Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice. De Sarro G; Ongini E; Bertorelli R; Aguglia U; De Sarro A Eur J Pharmacol; 1994 Sep; 262(1-2):11-9. PubMed ID: 7529182 [TBL] [Abstract][Full Text] [Related]
19. Novel potent AMPA/kainate receptor antagonists: synthesis and anticonvulsant activity of a series of 2-[(4-alkylsemicarbazono)-(4-amino-phenyl)methyl]-4,5-methylenedioxyphenylacetic acid alkyl esters. Micale N; Zappalà M; Grasso S; Puja G; De Sarro G; Ferreri G; De Sarro A; Toma L; De Micheli C J Med Chem; 2002 Sep; 45(20):4433-42. PubMed ID: 12238923 [TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships in a series of 2(1H)-quinolones bearing different acidic function in the 3-position: 6,7-dichloro-2(1H)-oxoquinoline-3-phosphonic acid, a new potent and selective AMPA/kainate antagonist with neuroprotective properties. Desos P; Lepagnol JM; Morain P; Lestage P; Cordi AA J Med Chem; 1996 Jan; 39(1):197-206. PubMed ID: 8568808 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]